메뉴 건너뛰기




Volumn 95, Issue 1, 1997, Pages 24-30

Cost-effectiveness of populationwide educational approaches to reduce serum cholesterol levels

Author keywords

cholesterol; coronary disease; cost benefit analysis; prevention

Indexed keywords

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; HEALTH EDUCATION; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; PATIENT EDUCATION; PRIORITY JOURNAL; RISK MANAGEMENT;

EID: 0031014387     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.1.24     Document Type: Article
Times cited : (61)

References (13)
  • 1
    • 0027243348 scopus 로고
    • Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II)
    • Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993;269:3015-3023.
    • (1993) JAMA , vol.269 , pp. 3015-3023
  • 2
    • 0023930868 scopus 로고
    • Report of the national cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults
    • The Expert Panel. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med. 1988;148:36-69.
    • (1988) Arch Intern Med , vol.148 , pp. 36-69
  • 3
    • 0024406675 scopus 로고
    • Impact of national guidelines for cholesterol risk screening: The Framingham offspring study
    • Wilson PWF, Christiansen JC, Anderson KM, Kannel WB. Impact of national guidelines for cholesterol risk screening: the Framingham Offspring Study. JAMA. 1989;262:41-44.
    • (1989) JAMA , vol.262 , pp. 41-44
    • Wilson, P.W.F.1    Christiansen, J.C.2    Anderson, K.M.3    Kannel, W.B.4
  • 5
    • 0024405294 scopus 로고
    • Relative impact of targeted versus populationwide cholesterol interventions on the incidence of coronary heart disease
    • Goldman L, Weinstein MC, Williams LW. Relative impact of targeted versus populationwide cholesterol interventions on the incidence of coronary heart disease. Circulation. 1989;80:254-260.
    • (1989) Circulation , vol.80 , pp. 254-260
    • Goldman, L.1    Weinstein, M.C.2    Williams, L.W.3
  • 6
    • 0021826599 scopus 로고
    • Projected effects of high-risk versus population-based preventions strategies in coronary heart disease
    • Kottke TE, Puska P, Salonen JT, Tuomilehto J, Nissinen A. Projected effects of high-risk versus population-based preventions strategies in coronary heart disease. Am J Epidemiol. 1985;121:697-704.
    • (1985) Am J Epidemiol , vol.121 , pp. 697-704
    • Kottke, T.E.1    Puska, P.2    Salonen, J.T.3    Tuomilehto, J.4    Nissinen, A.5
  • 7
    • 0026090020 scopus 로고
    • Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease
    • Goldman L, Weinstein MC, Goldman PA, Williams LW. Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease. JAMA. 1991;265:1145-1151.
    • (1991) JAMA , vol.265 , pp. 1145-1151
    • Goldman, L.1    Weinstein, M.C.2    Goldman, P.A.3    Williams, L.W.4
  • 9
    • 0025674465 scopus 로고
    • Reducing high blood cholesterol with drugs: Cost-effectiveness of pharmacologic management
    • Schulman K, Kinosian B, Jacobson T, Glick H, Eisenberg JM. Reducing high blood cholesterol with drugs: cost-effectiveness of pharmacologic management. JAMA. 1990;264:3025-3033.
    • (1990) JAMA , vol.264 , pp. 3025-3033
    • Schulman, K.1    Kinosian, B.2    Jacobson, T.3    Glick, H.4    Eisenberg, J.M.5
  • 10
    • 0028927214 scopus 로고
    • The cost-effectiveness of HMG-CoA reductase inhibitors to prevent coronary heart disease: Estimating the benefits of increasing HDL-C
    • Hamilton VH, Racicot FE, Zowall H, Coupal L, Grover SA. The cost-effectiveness of HMG-CoA reductase inhibitors to prevent coronary heart disease: estimating the benefits of increasing HDL-C. JAMA. 1995;273:1032-1038.
    • (1995) JAMA , vol.273 , pp. 1032-1038
    • Hamilton, V.H.1    Racicot, F.E.2    Zowall, H.3    Coupal, L.4    Grover, S.A.5
  • 13
    • 0025764923 scopus 로고
    • Cost effectiveness of incremental programmes for lowering serum cholesterol concentration: Is individual intervention worth while?
    • Kristiansen IS, Eggen AE, Thelle DS. Cost effectiveness of incremental programmes for lowering serum cholesterol concentration: is individual intervention worth while? Br Med J. 1991;302:1119-1122.
    • (1991) Br Med J , vol.302 , pp. 1119-1122
    • Kristiansen, I.S.1    Eggen, A.E.2    Thelle, D.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.